Literature DB >> 29396768

The relationship between medical expenses and the severity of peripheral arterial disease in Japan.

Akihiko Seo1, Kota Yamamoto2, Atsushi Akai1, Daisuke Akagi1, Toshio Takayama1, Katsuyuki Hoshina1.   

Abstract

The main objective is to examine whether the severity of peripheral arterial disease (PAD) affects the expenses and hospital stay of the patients who undergo bypass surgery below the inguinal ligament for PAD. Eighty consecutive patients who underwent infrainguinal bypass surgery for PAD between January 2012 and December 2014 were included in the study. Patients were divided into groups according to their critical limb ischemia (CLI) symptoms and the Wound, Ischemia, and Foot Infection (WIfI) classification. As endpoints, we assessed the duration of postoperative hospital stay and expenses during hospitalization. CLI was a significant factor for longer hospital stay and increased medical expenses (p = 0.009 and p = 0.001). In the patients with CLI, significant factors for longer hospital stay and increased medical expenses were (1) history of distal bypass (p = 0.33 and p = 0.003, respectively) and stage 4 local lower limb status in WIfI classification (p = 0.0007 and p = 0.053). PAD severity was associated with prolonged postoperative hospital stay and increased medical expenses. The presence or absence of CLI and its severity according to the WIfI classification correlated with medical expenses and hospital stay duration between the milder and severe groups.

Entities:  

Keywords:  Critical limb ischemia; Medical expenses; Peripheral arterial disease; WIfI classification

Mesh:

Year:  2018        PMID: 29396768     DOI: 10.1007/s00380-018-1127-3

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  21 in total

1.  [Diabetes and cardiovascular disease in NIPPON DATA].

Authors:  Aya Kadota; Katsuyuki Miura; Hirotsugu Ueshima
Journal:  Nihon Rinsho       Date:  2010-05

2.  Costs related to medical treatment for common cardiovascular risk factors.

Authors:  P Turek; J Lietava; V Foltan; V Kosmalova; A Dukat
Journal:  Bratisl Lek Listy       Date:  2010       Impact factor: 1.278

3.  The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing.

Authors:  Luke X Zhan; Bernardino C Branco; David G Armstrong; Joseph L Mills
Journal:  J Vasc Surg       Date:  2015-02-02       Impact factor: 4.268

4.  The direct medical cost of diabetes in Israel.

Authors:  Gabriel Chodick; Anthony D Heymann; Francis Wood; Ehud Kokia
Journal:  Eur J Health Econ       Date:  2005-06

5.  Resource use and risk factors in high-cost exacerbations of COPD.

Authors:  Jan B Oostenbrink; Maureen P M H Rutten-van Mölken
Journal:  Respir Med       Date:  2004-09       Impact factor: 3.415

6.  The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel.

Authors:  Gabriel Chodick; Avi Porath; Hillel Alapi; Tal Sella; Shira Flash; Francis Wood; Varda Shalev
Journal:  Health Policy       Date:  2010-01-12       Impact factor: 2.980

7.  The cost of moderate and severe COPD exacerbations to the Canadian healthcare system.

Authors:  N Mittmann; L Kuramoto; S J Seung; J M Haddon; C Bradley-Kennedy; J M Fitzgerald
Journal:  Respir Med       Date:  2007-12-20       Impact factor: 3.415

8.  A medical costs study of older patients with acute myocardial infarction and metabolic syndrome in hospital.

Authors:  Guan-qi Fan; Kai-li Fu; Cheng-wei Jin; Xiao-zhen Wang; Lu Han; Hui Wang; Ming Zhong; Yun Zhang; Wei Zhang; Zhi-hao Wang
Journal:  Clin Interv Aging       Date:  2015-01-23       Impact factor: 4.458

Review 9.  The Economic Costs of Type 2 Diabetes: A Global Systematic Review.

Authors:  Till Seuring; Olga Archangelidi; Marc Suhrcke
Journal:  Pharmacoeconomics       Date:  2015-08       Impact factor: 4.981

10.  Our treatment strategy for critical limb ischemia.

Authors:  Tetsuo Yamada; Kiyoshi Onishi; Makoto Utsunomiya; Masato Nakamura
Journal:  Int J Vasc Med       Date:  2013-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.